Entering text into the input field will update the search result below

Seelos Therapeutics secures composition of matter patent in Japan for SLS-007

patent application - approved

maybefalse/E+ via Getty Images

  • Seelos Therapeutics (SEEL -3.7%) has received an issued patent from the Japanese Patent Office (Number 6968839, titled: Structure-Based Peptide Inhibitors Of Alpha-Synuclein Aggregation), covering the composition of matter for SLS-007, a potentially disease-modifying gene therapy in Parkinson's disease (PD).

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.